article · Zagazig University Medical Journal
Background:Clinical research revealed that thromboembolic events are still a possibility for AF patients with low CHA2DS2-VASc scoresAim:To assess the ability of certain echocardiographic parameters and laboratory biomarkers to predict thromboembolic events in AF patients with low CHA2DS2-VASc scorePatients and methods: This is a Case-control study at Cardiology Department, Zagazig University Hospitals and Nasser Institute for Research and Treatment ,was conducted on 159 patients: group 1 included 53 non valvular AF patients having low CHA2DS2-VASc score with Acute Ischemic Stroke (AIS), group 2 included 53 non valvular AF patients having low CHA2DS2-VASc score but without AIS and group 3 included 53 controls without AF or AIS. All groups were investigated by certain echocardiography parameters including left atrial emptying fraction(LAEF) , left atrial volume index (LAVI) , left atrial appendage flow velocity(LAA FV) , mitral annular velocity (E′) and E/e′ ratio , also they were investigated by some laboratory markers including platelet count , red cell distribution width(RDW), platelet distribution width(PDW) , creatinine level , D-dimer level and troponin I.Results:Results: The Receiver Operating Characteristic (ROC) curve analysis showed that several echocardiographic parameters had significant predictive value for stroke ,these parameters were LAVI , LAeF, E/e' ratios, and LAAFV.Also the ROC curve analysis showed that PDW, D-dimer, and troponin had significant predictive value . A novel stroke risk scoring model was developedConclusion :The novel stroke risk score model may enhance prediction of LAA thrombus in non valvular AF patients with low CHADS-VASc score (0 in male,1 in female)
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/zumj.2024.274151.3224
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.